Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Foot and Mouth Disease (FMD) Vaccine
... the year 2023, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2023-2030. Conventional Vaccines, one of the segments analyzed in the report, is expected to ... Read More
-
Metabolic Disorder Therapeutics
... by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Diabetes Therapeutics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$91.9 Billion by ... Read More
-
Non-Invasive Prenatal Testing (NIPT)
... reach US$9.2 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2023-2030. NIPT Consumables & Reagents, one of the segments analyzed in the report, is expected to record a 8.4% CAGR ... Read More
-
Pharmaceutical Grade Silica Gel
... reach US$184.5 Million by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Desiccant Application, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Pharmacovigilance
... of 9.2% over the analysis period 2023-2030. Contract Outsourcing, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
Smart Insulin Pens and Pumps
... is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Smart Insulin Pumps, one of the segments analyzed in the report, is expected to record a ... Read More
-
Transcatheter Pulmonary Valves
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Balloon-Expanded Technology, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$74.1 Million by ... Read More
-
Vaccine Contract Manufacturing
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Attenuated Vaccine, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.6 Billion by ... Read More
-
Vaginitis Therapeutics
... at a CAGR of 7.5% over the analysis period 2023-2030. Anti-Bacterial, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.7 Billion by the end of the ... Read More
-
Produce Packaging Trays
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Growers / Shippers End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.0 ... Read More
-
Animal Antibiotics and Antimicrobials
... reach US$7.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Tetracycline, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.6 ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
Connected Drug Delivery Devices
... reach US$22.9 Billion by 2030, growing at a CAGR of 21.7% over the analysis period 2023-2030. Diabetes Management Application, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and ... Read More
-
Therapeutic Respiratory Devices
... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$32.3 ... Read More
-
Implantable Drug Delivery Devices
... reach US$41.2 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Label-free Array Systems
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Surface Plasmon Resonance (SPR) Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach ... Read More
-
Office Administrative Services
... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$62.1 Billion ... Read More
-
Behavioral Rehabilitation
... at a CAGR of 5.8% over the analysis period 2023-2030. Outpatient Setting, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$207.4 Billion by the end of ... Read More
-
Bioanalytical Testing Services
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Small Molecule Type, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.7 Billion ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
Respiratory Protection Equipment
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion ... Read More
-
Glaucoma Therapeutics
... at a CAGR of 3.5% over the analysis period 2023-2030. Prostaglandins Analogs, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Hereditary Angioedema
... at a CAGR of 7.7% over the analysis period 2023-2030. C1 Esterase Inhibitors, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.5 Billion by the end ... Read More
-
IoT in Intelligent Transportation System
... is expected to reach US$543.4 Billion by 2030, growing at a CAGR of 20.0% over the analysis period 2023-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 21.7% ... Read More
-
Motion Sickness Treatment
... by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Anticholinergic Treatment, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$532.7 Million by ... Read More
Research Assistance
